Predicted 10-year CVD risk according to model A (QRISK2) | Predicted 10-year CVD risk according to model A (QRISK2) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
5–6% | 6–7% | 7–8% | 8–9% | 9–10% | < 10% | 10–11% | 11–12% | 12–13% | 13–14% | 14–15% | > 10% | |
Female (N = 200,000) | ||||||||||||
N | 5163 | 4356 | 3561 | 3080 | 2602 | 169,491 | 2321 | 2086 | 1849 | 1617 | 1525 | 30,509 |
Model B | 21 (0%) | 64 (1%) | 105 (3%) | 392 (13%) | 547 (21%) | 1140 (1%) | 1000 (43%) | 114 (5%) | 3 (0%) | 2 (0%) | 4 (0%) | 1128 (4%) |
Model C | 73 (1%) | 142 (3%) | 220 (6%) | 374 (12%) | 592 (23%) | 1446 (1%) | 1260 (54%) | 264 (13%) | 33 (2%) | 7 (0%) | 5 (0%) | 1575 (5%) |
Model D | 63 (1%) | 108 (2%) | 206 (6%) | 388 (13%) | 689 (26%) | 1498 (1%) | 1204 (52%) | 757 (36%) | 461 (25%) | 286 (18%) | 203 (13%) | 3252 (11%) |
Model E | 69 (1%) | 116 (3%) | 236 (7%) | 466 (15%) | 703 (27%) | 1649 (1%) | 1276 (55%) | 833 (40%) | 533 (29%) | 320 (20%) | 223 (15%) | 3645 (12%) |
Model F | 100 (2%) | 184 (4%) | 310 (9%) | 540 (18%) | 765 (29%) | 1978 (1%) | 1328 (57%) | 906 (43%) | 589 (32%) | 367 (23%) | 253 (17%) | 3953 (13%) |
Male (N = 200,000) | ||||||||||||
N | 7422 | 6077 | 5364 | 4483 | 3922 | 158,036 | 3355 | 3108 | 2710 | 2421 | 2283 | 41,964 |
Model B | 17 (0%) | 33 (1%) | 91 (2%) | 255 (6%) | 583 (15%) | 983 (1%) | 733 (22%) | 51 (2%) | 0 (0%) | 0 (0%) | 0 (0%) | 784 (2%) |
Model C | 37 (0%) | 86 (1%) | 200 (4%) | 318 (7%) | 728 (19%) | 1384 (1%) | 1042 (31%) | 95 (3%) | 4 (0%) | 1 (0%) | 1 (0%) | 1143 (3%) |
Model D | 25 (0%) | 63 (1%) | 164 (3%) | 341 (8%) | 1220 (31%) | 1823 (1%) | 1625 (48%) | 1008 (32%) | 627 (23%) | 375 (15%) | 266 (12%) | 4146 (10%) |
Model E | 30 (0%) | 66 (1%) | 191 (4%) | 505 (11%) | 1146 (29%) | 1953 (1%) | 1792 (53%) | 1129 (36%) | 705 (26%) | 435 (18%) | 302 (13%) | 4744 (11%) |
Model F | 126 (2%) | 267 (4%) | 483 (9%) | 750 (17%) | 1146 (29%) | 2850 (2%) | 1896 (57%) | 1337 (43%) | 888 (33%) | 539 (22%) | 375 (16%) | 5563 (13%) |